Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1996 | 1 |
1999 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for
K. simjee
Your search for
K. Sivjee
retrieved no results
Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis.
Aliment Pharmacol Ther. 1996 Jun;10(3):397-401. doi: 10.1111/j.0953-0673.1996.00397.x.
Aliment Pharmacol Ther. 1996.
PMID: 8791969
Clinical Trial.
BACKGROUND: Pantoprazole is a substituted benzimidazole which is a potent inhibitor of gastric acid secretion by its action upon H+, K+-ATPase. METHODS: Pantoprazole 40 mg and 80 mg were compared in a randomized double-blind study in 192 out-patients with stage II or III ( …
BACKGROUND: Pantoprazole is a substituted benzimidazole which is a potent inhibitor of gastric acid secretion by its action upon H+, K …
Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis-a 2-year follow-up.
Van Rensburg CJ, Honiball PJ, Van Zyl JH, Grundling HD, Eloff FP, Spies SK, Simjee AE, Theron I, Fischer R, Louw JA.
Van Rensburg CJ, et al.
Aliment Pharmacol Ther. 1999 Aug;13(8):1023-8. doi: 10.1046/j.1365-2036.1999.00573.x.
Aliment Pharmacol Ther. 1999.
PMID: 10468676
Free article.
Clinical Trial.
BACKGROUND: Pantoprazole is a benzimidazole derivative which selectively inhibits the proton pump H+, K+-ATPase, necessary for the final step in gastric acid secretion. ...
BACKGROUND: Pantoprazole is a benzimidazole derivative which selectively inhibits the proton pump H+, K+-ATPase, necessary for the fi …
Item in Clipboard
Cite
Cite